2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTÉ stent in all-comers: a randomized open label trial)

Study Questions:

What is the safety and efficacy of the XIENCE V everolimus-eluting stent (EES) compared with the TAXUS LIBERTE paclitaxel-eluting stent (PES) at 2-year follow-up in daily practice?